Contura Orthopaedics Ltd
James Bayes-Garrould is an accomplished professional in the field of orthopaedics, currently serving as UK Business Unit Manager at Contura Orthopaedics Ltd since August 2022. Previously, James held multiple roles at DePuy Synthes Companies from September 2016 to August 2022, including Joints Development Manager and Sales Specialist in Orthopaedics for hips and knees. James began a career in sales at Smith & Nephew from July 2011 to August 2016 as a Territory Sales Manager in the Reconstruction Division, consistently achieving sales targets. James's experience also includes a position as Territory Sales Manager for Endo Mechanical Intelligent Devices at Covidien from August 2009 to August 2011. An alumnus of Oxford Brookes University, James holds a Bachelor’s Degree in Retail and Business Management, and demonstrates a solid academic foundation with A Levels from Greshams School.
This person is not in any teams
Contura Orthopaedics Ltd
Pioneering, proven pain treatment for knee OA. Arthrosamid® — The first and only synovial scaffold administered via a single injectable for long-lasting pain relief. Arthrosamid® is a single, minimally invasive, long-lasting knee OA treatment — a non-biodegradable injectable polyacrylamide hydrogel (2.5 iPAAG) for intra-articular use. Supported by more than two decades of research, Arthrosamid® is proven to be safe and effective, offering long-lasting pain relief in a single non-biodegradable injectable polyacrylamide hydrogel (2.5 iPAAG) for knee OA patients.